Navidea Biopharmaceuticals (NAVB) Short Interest Ratio & Short Volume $0.0002 0.00 (0.00%) As of 07/16/2025 11:02 AM Eastern Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsOptions ChainSEC FilingsShort InterestTrendsBuy This Stock Navidea Biopharmaceuticals Short Interest DataNavidea Biopharmaceuticals (NAVB) has a short interest of 400 shares, representing 0.00% of the float (the number of shares available for trading by the public). This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 8,592 shares to cover all short positions.Current Short Interest400 sharesPrevious Short Interest400 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$0.40Short Interest Ratio0.1 Days to CoverLast Record DateJune 30, 2025Outstanding Shares100,084,000 sharesShort Percent of Float0.00%Today's Trading Volume1,164 sharesAverage Trading Volume8,592 sharesToday's Volume Vs. Average14% Short Selling Navidea Biopharmaceuticals? Sign up to receive the latest short interest report for Navidea Biopharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNAVB Short Interest Over TimeNAVB Days to Cover Over TimeNAVB Percentage of Float Shorted Over Time Navidea Biopharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/2025400 shares $0.40 No Change0.0%0.1 $0.00 6/15/2025400 shares $0.28 No Change0.0%0.1 $0.00 5/31/2025400 shares $0.28 No Change0.0%0.4 $0.00 5/15/2025400 shares $0.28 +33.3%N/A0.4 $0.00 4/30/2025300 shares $0.18 -25.0%N/A0 $0.00 4/15/2025400 shares $0.24 No ChangeN/A0.1 $0.00 3/14/2025400 shares $0.04 No ChangeN/A0.2 $0.00 2/14/2025400 shares $0.28 No ChangeN/A0 $0.00 1/31/2025400 shares $0.40 No ChangeN/A0.1 $0.00 1/15/2025400 shares $0.04 No ChangeN/A0 $0.00 Get the Latest News and Ratings for NAVB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Navidea Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 6/15/2023570,200 shares $51.32 thousand -35.3%4.5%0.1 $0.09 5/31/2023881,100 shares $81.06 thousand +1,888.9%3.7%0.4 $0.09 5/15/202344,300 shares $0.00 -92.5%0.2%0.1 $0.00 4/30/2023592,800 shares $0.00 +28.7%2.7%4.1 $0.00 4/15/2023460,700 shares $133.05 thousand -7.0%2.1%3.8 $0.29 3/31/2023495,500 shares $0.00 +6.3%2.3%3.7 $0.00 3/15/2023466,100 shares $0.00 +4.2%2.2%3.1 $0.00 2/28/2023447,300 shares $0.00 +2.0%2.1%3 $0.00 2/15/2023438,500 shares $0.00 +38.2%2.1%2.9 $0.00 1/31/2023317,300 shares $0.00 +660.9%1.5%2.3 $0.00 1/15/202341,700 shares $0.00 +118.3%0.2%0.4 $0.00 12/30/202219,100 shares $0.00 -83.7%0.1%0.2 $0.00 12/15/2022117,200 shares $0.00 -12.5%0.5%1.7 $0.00 11/30/2022133,900 shares $0.00 +27.5%0.6%1.3 $0.00 11/15/2022105,000 shares $0.00 -8.2%0.5%0.8 $0.00 10/31/2022114,400 shares $0.00 -50.2%0.5%0.7 $0.00 10/15/2022229,900 shares $0.00 -50.7%1.1%1.4 $0.00 9/30/2022466,700 shares $0.00 +20.2%2.2%3 $0.00 9/15/2022388,300 shares $0.00 +60.3%1.8%2.6 $0.00 8/31/2022242,300 shares $0.00 +319.9%1.1%2.3 $0.00 8/15/202257,700 shares $0.00 -2.9%0.3%0.9 $0.00 7/31/202259,400 shares $0.00 -38.1%0.3%1.4 $0.00 7/15/202296,000 shares $0.00 -5.0%0.4%1.9 $0.00 6/30/2022101,000 shares $0.00 +45.3%0.5%0.3 $0.00 6/15/202269,500 shares $0.00 -16.3%N/A0.2 $0.00 5/31/202283,000 shares $0.00 +2.1%0.4%0.2 $0.00 5/15/202281,300 shares $0.00 -63.6%0.4%0.2 $0.00 4/30/2022223,300 shares $0.00 +121.5%1.0%0.6 $0.00 4/15/2022100,800 shares $0.00 -1.0%0.5%0.3 $0.00 3/31/2022101,800 shares $0.00 -33.4%0.5%1.6 $0.00Trump’s Exec Order #14154 could be a “Millionaire-Maker” (Ad)Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape. For the moment, you can watch this interview free of charge – just click here. 3/15/2022152,800 shares $0.00 -15.9%0.7%2.1 $0.00 2/28/2022181,600 shares $0.00 -7.6%0.8%2.2 $0.00 2/15/2022196,500 shares $0.00 -12.4%0.9%2.3 $0.00 1/31/2022224,400 shares $0.00 -1.4%1.0%2.4 $0.00 1/15/2022227,500 shares $0.00 +1.9%1.1%3.3 $0.00 12/31/2021223,200 shares $0.00 +63.9%1.0%3.1 $0.00 12/15/2021136,200 shares $0.00 -7.1%0.6%2.1 $0.00 11/30/2021146,600 shares $0.00 +4.1%0.7%2.3 $0.00 11/15/2021140,900 shares $0.00 -10.8%0.6%2.4 $0.00 10/29/2021157,900 shares $0.00 -9.3%0.7%2.9 $0.00 10/15/2021174,100 shares $0.00 -7.0%0.8%4 $0.00 9/30/2021187,200 shares $0.00 +13.8%0.9%3 $0.00 9/15/2021164,500 shares $0.00 -5.4%0.8%2.5 $0.00 8/31/2021173,800 shares $0.00 +9.3%0.8%2.4 $0.00 8/13/2021159,000 shares $0.00 -17.0%0.7%1.4 $0.00 7/30/2021191,500 shares $0.00 -4.3%0.9%1.5 $0.00 7/15/2021200,000 shares $0.00 -1.6%1.0%1.4 $0.00 6/30/2021203,200 shares $0.00 +12.3%1.0%1.4 $0.00 6/15/2021181,000 shares $0.00 +30.2%0.9%0.9 $0.00 5/28/2021139,000 shares $0.00 -23.4%0.7%0.7 $0.00 5/14/2021181,500 shares $0.00 +5.5%N/A0.8 $0.00 4/30/2021172,000 shares $0.00 -7.2%N/A0.6 $0.00 4/15/2021185,300 shares $290.92 thousand -15.5%N/A0.5 $1.57 3/31/2021219,400 shares $355.43 thousand +49.3%N/A0.6 $1.62 3/15/2021147,000 shares $255.78 thousand -22.3%N/A0.4 $1.74 2/26/2021189,200 shares $389.75 thousand +13.8%N/A0.6 $2.06 2/12/2021166,200 shares $402.20 thousand -33.0%N/A0.5 $2.42 1/29/2021248,100 shares $615.29 thousand -8.4%N/A0.6 $2.48 1/15/2021270,800 shares $785.32 thousand -2.9%N/A0.9 $2.90 12/31/2020279,000 shares $558 thousand -1.6%N/A1.1 $2.00 12/15/2020283,500 shares $532.98 thousand +9.0%N/A1.2 $1.88 11/30/2020260,000 shares $624 thousand +32.9%N/A1.1 $2.40 11/15/2020195,600 shares $539.86 thousand +3.4%N/A0.8 $2.76 10/30/2020189,100 shares $457.62 thousand -3.3%N/A1.1 $2.42 10/15/2020195,600 shares $535.94 thousand -11.1%N/A0.8 $2.74 9/30/2020220,100 shares $594.27 thousand +11.4%N/A0.7 $2.70 9/15/2020197,500 shares $582.63 thousand -12.7%1.1%0.6 $2.95 8/31/2020226,100 shares $671.52 thousand +5.0%1.3%0.5 $2.97 8/14/2020215,300 shares $704.03 thousand -5.2%1.3%0.3 $3.27 7/31/2020227,000 shares $1.09 million -37.0%1.3%0.1 $4.78 NAVB Short Interest - Frequently Asked Questions What is Navidea Biopharmaceuticals' current short interest? Short interest is the volume of Navidea Biopharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of June 30th, traders have sold 400 shares of NAVB short. 0.00% of Navidea Biopharmaceuticals' shares are currently sold short. Learn More on Navidea Biopharmaceuticals' current short interest. What is a good short interest percentage for Navidea Biopharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.00% of Navidea Biopharmaceuticals' floating shares are currently sold short. How does Navidea Biopharmaceuticals' short interest compare to its competitors? 0.00% of Navidea Biopharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Navidea Biopharmaceuticals: Scopus BioPharma Inc. (0.03%), Evelo Biosciences, Inc. (0.04%), Comera Life Sciences Holdings, Inc. (0.02%), Genocea Biosciences, Inc. (0.33%), Ampio Pharmaceuticals, Inc. (0.01%), Aridis Pharmaceuticals, Inc. (0.04%), Statera Biopharma, Inc. (0.15%), eFFECTOR Therapeutics, Inc. (0.13%), OncoSec Medical Incorporated (0.00%), PaxMedica, Inc. (0.01%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks. What does it mean to sell short Navidea Biopharmaceuticals stock? Short selling NAVB is an investing strategy that aims to generate trading profit from Navidea Biopharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Navidea Biopharmaceuticals? A short squeeze for Navidea Biopharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NAVB, which in turn drives the price of the stock up even further. How often is Navidea Biopharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NAVB, twice per month. The most recent reporting period available is June, 30 2025. More Short Interest Resources from MarketBeat Related Companies SCPS Short Interest EVLO Short Interest CMRA Short Interest GNCAQ Short Interest AMPE Short Interest ARDS Short Interest STAB Short Interest EFTR Short Interest ONCSQ Short Interest PXMD Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:NAVB) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Navidea Biopharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Navidea Biopharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NAVB Stock Alerts